Stability of oxycodone hydrochloride for injection in dextrose and saline solutions

Canadian Journal of Hospital Pharmacy

Volumn 55, Issue 4, 2002, Pages 272-277

  Turnbull, Kathy ^a   Bielech, Monique ^a   Walker, Scott E ^a   Law, Shirley ^a  

^a GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

Drug storage; Oxycodone hydrochloride; Stability

Indexed keywords

GLUCOSE; OXYCODONE; POLYVINYLCHLORIDE; SODIUM CHLORIDE; WATER;

ACCURACY; ANALYTICAL ERROR; ARTICLE; COLOR; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DILUTION; DOSE RESPONSE; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; INJECTION; LIQUID CHROMATOGRAPHY; PH; PHYSICAL EXAMINATION; PRECIPITATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIATION DETECTION; REPRODUCIBILITY; STANDARD; SYRINGE; TEMPERATURE; TIME; ULTRAVIOLET RADIATION;

EID: 0036751344     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Coons CE, Soon M. Portable narcotic infusion devices in Canada. Can J Hosp Pharm 1989;42:235-8.
2. Swanson G, Smith J, Bulich R, New P, Shiffman R. Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients. J Clin Oncol 1989;7:1903-8.
3. Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain. J Clin Pharmacol Ther 1990;47:639-46.
4. Maddocks I, Somogyi A, Abbott F, Hayball P, Parker D. Attentuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone. J Pain Symptom Manage 1996;12:182-9.
5. Bruera E, Kuchn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6-9.
6. Gagnon B, Bielech M, Watanabe S, Walker P, Hanson J, Bruera E. The use of intermittent subcutaneous injections of oxycodone for opioid rotation in patients with cancer pain. Support Care Cancer 1999;7:265-70.
7. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, et al. Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. J Pharm Sci 1992;81:309-12.
8. Trissel LA. Avoiding common flaws in stability and compatibility studies of injectable drugs. Am J Hosp Pharm 1983;40:1159-60.
9. Trissel LA, Flora KP. Stability studies: five years later. Am J Hosp Pharm 1988;45:1569-71.
10. Box GEP, Cox DR. An analysis of transformations. J R Stat Soc Ser B 1964;26:211-43.
11. Sclove SL. (Y vs X) or (log Y vs X)? Technometrics 1972;14:391-403.
12. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med 1978;299:690-4.
13. Stolley PD, Strom BL. Sample size calculations for clinical pharmacology studies. Clin Pharmacol Ther 1986;39:489-90.